Esophagogastric fistula: A complication of Crohn's disease: Case report and review of the literature

American Journal of Gastroenterology

Volumn 93, Issue 8, 1998, Pages 1381-1383

  Rholl, James C ^a   Yavorski, Robert T ^b   Cheney, Christopher P ^b   Wong, Roy K H ^b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MESALAZINE; METRONIDAZOLE; OMEPRAZOLE; PREDNISONE; TRIAMCINOLONE;

ADULT; ARTICLE; CASE REPORT; CECUM; CLINICAL FEATURE; COLON CROHN DISEASE; DIET THERAPY; DISEASE COURSE; DUODENUM; ESOPHAGUS FISTULA; HISTOPATHOLOGY; HUMAN; ILEUM; MALE; ORAL DRUG ADMINISTRATION; OROPHARYNX; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT DISEASE; STOMACH FISTULA;

EID: 0032148057     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.428_i.x     Document Type: Article

References (21)

1. 1. Franklin R, Taylor S. Nonspecific granulomatous (regional) esophagitis. J Thorac Surg 1950;19:292-7.
2. 2. Beck PL, Lay TE, Blustein PK. Esophageal Crohn's disease: Treat the inflammation, not just the symptoms. Dig Dis Sci 1995;40:837.
3. 3. Mashako MNL, Cezard JP, Navarro J, et al. Crohn's disease lesions in the upper gastrointestinal tract: Correlation between clinical, radiological, endoscopic, and histological features in adolescents and children. J Pediatr Gastroenterol Nutr 1989;8:442-6.
4. 4. Ruuska T, Vaajalahti P, Arajarvi P, et al. Prospective evaluation of upper gastrointestinal mucosal lesions in children with ulcerative colitis and Crohn's disease. J Pediatr Gastroenterol Nutr 1994;19: 181-6.
5. 5. Lewin KJ, Ridell RH, Weinstein WM. Inflammatory disorders of the esophagus: Reflux and nonreflux types. In: Lewin KJ, Ridell RH, Weinstein WM, eds. Gastrointestinal pathology and its clinical implications. New York: Igaku-Shoin, 1992:342-3.
6. 6. D'Haens G, Rutgeerts P, Geboes K, et al. The natural history of esophageal Crohn's disease: Three distinct patterns of evolution. Gastrointest Endosc 1994;40:296-300.
7. 7. Madden JL, Ravid JM, Haddad JR. Regional esophagitis: A specific entity simulating Crohn's disease. Ann Surg 1969; 170:351-68.
8. 8. Prezmioslo RT, Mee AS. Omeprazole in possible esophageal Crohn's disease. Dig Dis Sci 1994;39:1594-5.
9. 9. Ghahremani GG, Gore RM, Breuer RI, et al. Esophageal manifestations of Crohn's disease. Gastrointest Radiol 1982;7:199-203.
10. 10. Mathis G, Sutterlutti G, Dirschmid K, et al. Crohn's disease of the esophagus: Dilation of stricture and fibrin sealing of fistulas. Endoscopy 1994;26:508.
11. 11. Malchow H, Glombitza R, Vestweber KH, et al. Crohn's esophagotracheal fistula: Failure of a Nitinol coated stent. Gastroenterology 1996;110:A184 (abstract).
12. 12. Cynn WS, Chon HK, Gureghian PA, et al. Crohn's disease of the esophagus. AJR 1975;125:359-64.
13. 13. Achenbach H, Lynch JP, Dwight RW. Idiopathic ulcerative esophagitis, report of a case. N Engl J Med 1956;255:456-9.
14. 14. Davidson JT, Sawyer JL. Crohn's disease of the esophagus. Am Surg 1983;49:168-72.
15. 15. Ramboer C, Verhamme M, Dhondt E, et al. Endoscopic treatment of stenosis in recurrent Crohn's disease with balloon dilation combined with local corticosteroid injection. Gastrointest Endosc 1995;42: 252-5.
16. 16. Lee M, Kubik CM, Polhamus CD, et al. Preliminary experience with endoscopic intralesional steroid injection for refractory upper gastrointestinal strictures. Gastrointest Endosc 1995;41:598-600.
17. 17. Anderson JM. Treatment of esophageal strictures with intralesional steroids. Gastrointest Endosc 1995;41:333 (abstract).
18. 18. Rupp T, Earle D, Dick P, et al. Randomized trial of dilation plus intralesional steroids vs. dilation alone for benign gastroesophageal strictures. Gastrointest Endosc 1993;39:287 (abstract).
19. 19. Deguzman LJ, Evans JR. Endoscopic treatment of benign extra-esophageal gastrointestinal tract strictures via combined pneumatic dilation and interlesional steroid injection. Gastrointest Endosc 1996;43:349 (abstract).
20. 20. Schreiber S, Hamling J, Zehnter E, et al. Renal tubular dysfunction in patients with inflammatory bowel disease treated with aminosalicylate. Gut 1997;40:761-6.
21. 21. Hamling J, Raedler A, Helmchen U, et al. 5-Aminosalicylic acid-associated renal tubular acidosis with decreased renal function in Crohn's disease. Digestion 1997;58:304-7.